s 9788 has been researched along with Thyroid Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibassier, J; Leclech, G; Lucas, C; Massart, C; Pourquier, P; Raoul, M; Robert, J | 1 |
| Darcel, F; Denais, A; Gibassier, J; Lucas, C; Massart, C; Maugendre, S; Raoul, M | 1 |
2 other study(ies) available for s 9788 and Thyroid Neoplasms
| Article | Year |
|---|---|
Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Medullary; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Glutathione; Glutathione Transferase; Humans; Neoplasm Proteins; Piperidines; Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Thyroid Neoplasms; Triazines; Verapamil | 1995 |
Effect of S9788 on the efficiency of doxorubicin in vivo and in vitro in medullary thyroid carcinoma xenograft.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Doxorubicin; Drug Synergism; Female; Humans; Mice; Mice, Nude; Piperidines; Thyroid Neoplasms; Triazines; Tumor Cells, Cultured | 1996 |